These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11701762)

  • 1. Inhibition of the rat blood-brain barrier choline transporter by manganese chloride.
    Lockman PR; Roder KE; Allen DD
    J Neurochem; 2001 Nov; 79(3):588-94. PubMed ID: 11701762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier choline transport in the senescent rat.
    Allen DD; Smith QR
    Neurosci Lett; 1999 Dec; 277(3):198-202. PubMed ID: 10626847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.
    Allen DD; Smith QR
    J Neurochem; 2001 Feb; 76(4):1032-41. PubMed ID: 11181822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cation transport specificity at the blood-brain barrier.
    Lockman PR; McAfee JH; Geldenhuys WJ; Allen DD
    Neurochem Res; 2004 Dec; 29(12):2245-50. PubMed ID: 15672546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.
    Allen DD; Lockman PR; Roder KE; Dwoskin LP; Crooks PA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1268-74. PubMed ID: 12604705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of brain choline uptake by isoarecolone and lobeline derivatives: implications for potential vector-mediated brain drug delivery.
    Metting TL; Burgio DE; Terry AV; Beach JW; McCurdy CR; Allen DD
    Neurosci Lett; 1998 Dec; 258(1):25-8. PubMed ID: 9876043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier transport of choline is reduced in the aged rat.
    Mooradian AD
    Brain Res; 1988 Feb; 440(2):328-32. PubMed ID: 3359216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of choline uptake by N-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood-brain barrier.
    Geldenhuys WJ; Lockman PR; Philip AE; McAfee JH; Miller BL; McCurdy CR; Allen DD
    J Drug Target; 2005 May; 13(4):259-66. PubMed ID: 16051538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake.
    Crossgrove JS; Yokel RA
    Neurotoxicology; 2004 Mar; 25(3):451-60. PubMed ID: 15019308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier.
    Kang YS; Terasaki T; Ohnishi T; Tsuji A
    J Pharmacobiodyn; 1990 Jun; 13(6):353-60. PubMed ID: 2231266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
    Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese toxicokinetics at the blood-brain barrier.
    Yokel RA; Crossgrove JS
    Res Rep Health Eff Inst; 2004 Jan; (119):7-58; discussion 59-73. PubMed ID: 15043400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier.
    Lockman PR; Manda VK; Geldenhuys WJ; Mittapalli RK; Thomas F; Albayati ZF; Crooks PA; Dwoskin LP; Allen DD
    J Pharmacol Exp Ther; 2008 Jan; 324(1):244-50. PubMed ID: 17921191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes.
    Inazu M; Takeda H; Matsumiya T
    J Neurochem; 2005 Sep; 94(5):1427-37. PubMed ID: 16000150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
    Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
    Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
    Mehta DC; Short JL; Nicolazzo JA
    Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic manganese chloride treatment expressed as age-dependent, transient changes in rat brain synaptosomal uptake of amines.
    Lai JC; Leung TK; Guest JF; Davison AN; Lim L
    J Neurochem; 1982 Mar; 38(3):844-7. PubMed ID: 7057197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels.
    Crossgrove JS; Yokel RA
    Neurotoxicology; 2005 Jun; 26(3):297-307. PubMed ID: 15935202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
    Suzuki T; Fukami T; Tomono K
    Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of distorted iron regulation in the blood-CSF barrier and regional blood-brain barrier following in vivo subchronic manganese exposure.
    Li GJ; Choi BS; Wang X; Liu J; Waalkes MP; Zheng W
    Neurotoxicology; 2006 Sep; 27(5):737-44. PubMed ID: 16545456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.